This infographic from the World Gastroenterology Organisation shows a global perspective of heartburn, including worldwide prevalence ranges, common presenting symptoms, and complications of untreated...
Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.
An article was recently published about the key advancements and trends in gastroenterology and hepatology over the past decade. Do you agree with the authors’ choices? Take our poll to voice your opinion!
...
It has been unclear whether nonalcoholic fatty liver disease is directly related to cardiovascular disease or whether this relationship is confounded by metabolic factors of NAFLD and CVD. What do you...
Do you know the percentage of patients with nonalcoholic fatty liver disease who will develop progressive disease? Test your knowledge with our pop quiz!
The gut microbiome affects the development and progression of nonalcoholic fatty liver disease. Do you know which part of the hepatic portal system connects the liver with the intestine?
In recent years, the obesity pandemic has contributed to an increase in prevalence of nonalcoholic fatty liver disease, though body mass index is only one risk factor. Do you know the estimated global...
The International Organization for the Study of Inflammatory Bowel Diseases recently released a dietary guideline for IBD to provide the latest expert advice on foods and additives that may alleviate—or...
Many patients with CP experience pain caused by obstruction in the pancreatic duct. Do you know what the ACG recommends as first-line therapy for pain relief in patients with CP? Take our short quiz to find...
